More tools:Markets·Screener·Research·Chat

Bausch + Lomb Corporation (BLCO) Financial Statements

Bausch + Lomb Corporation
SIC 3851 · OPHTHALMIC GOODS
FIGI BBG014KG1GY8
XNYS · usd
17.83▲ 0.10 (0.58%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close17.73
Day's Range17.47 – 17.96
52-Week Range13.77 – 18.93
Volume335.6K
Avg Volume402.0K
Share Statistics
Shares Outstanding
Employees13.0K
ExchangeXNYS
Listed2022-05-06
Share count as of July 22, 2026
Loading Income Statement…
Key questions about Bausch + Lomb Corporation (BLCO)
What is Bausch + Lomb Corporation's Market Cap?
Bausch + Lomb Corporation's Market Cap is $6.4B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's Enterprise Value?
Bausch + Lomb Corporation's Enterprise Value is $11.1B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's Price / Sales?
Bausch + Lomb Corporation's Price / Sales is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's EV / Revenue?
Bausch + Lomb Corporation's EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's EV / EBITDA?
Bausch + Lomb Corporation's EV / EBITDA is 15.0×, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's Revenue (TTM)?
Bausch + Lomb Corporation's Revenue (TTM) is $5.3B, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's Net Income (TTM)?
Bausch + Lomb Corporation's Net Income (TTM) is -$171.0M, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's EBITDA?
Bausch + Lomb Corporation's EBITDA is $734.0M, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's Diluted EPS (TTM)?
Bausch + Lomb Corporation's Diluted EPS (TTM) is -0.48, based on as-reported figures from SEC (XBRL) filings.
What is Bausch + Lomb Corporation's EBITDA Margin?
Bausch + Lomb Corporation's EBITDA Margin is 13.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
Total revenues
YoY growth+9.1%+9.4%+9.8%+7.1%
Expenses
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues———
Selling, general and administrative (Note 4)
Research and development
Amortization of intangible assets
Other expense, net
Total expenses
% of revenue94.0%97.3%92.0%92.6%
Operating income (loss)
% of revenue6.0%2.7%8.0%7.4%
Interest income
Interest expense
Loss on extinguishment of debt
Foreign exchange and other
Loss before provision for income taxes
Benefit from (provision for) income taxes
Net loss
% of revenue-0.7%-5.6%-4.1%-2.0%
Net income attributable to noncontrolling interest
Net loss attributable to Bausch + Lomb Corporation
% of revenue-1.0%-5.7%-4.1%-2.2%
Basic loss per share attributable to Bausch + Lomb Corporation (in usd per share)
Diluted loss per share attributable to Bausch + Lomb Corporation (in usd per share)